Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal masses: urologic management

D K Ornstein1, C G Arcangeli, G L Andriole

  • 1Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri.

Magnetic Resonance Imaging Clinics of North America
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.

BMC urology·2021
Same author

Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.

Urology·2019
Same author

The association of atrophy in baseline prostate biopsy and lower prostate cancer grade in radical prostatectomy specimens.

Scandinavian journal of urology·2019
Same author

The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens.

Prostate cancer and prostatic diseases·2017
Same author

Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE.

Prostate cancer and prostatic diseases·2016
Same author

Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.

Prostate cancer and prostatic diseases·2016
Same journal

Cardiovascular Magnetic Resonance: Innovation, Integration, and Clinical Impact.

Magnetic resonance imaging clinics of North America·2026
Same journal

Advances and Innovations in Cardiovascular Magnetic Resonance.

Magnetic resonance imaging clinics of North America·2026
Same journal

The Future of Cardiac Magnetic Resonance: Navigating Ultra-High and Low-Field Imaging (Part 2).

Magnetic resonance imaging clinics of North America·2026
Same journal

Artificial Intelligence Applications in Cardiac MR Imaging.

Magnetic resonance imaging clinics of North America·2026
Same journal

Climate Change and Globally Sustainable Cardiovascular Magnetic Resonance.

Magnetic resonance imaging clinics of North America·2026
Same journal

Strain Imaging in Heart Failure.

Magnetic resonance imaging clinics of North America·2026
See all related articles

This review covers diagnosing solid renal masses and staging renal cell carcinoma. It examines controversial management strategies, including surgery, and treatments for metastatic disease.

Area of Science:

  • Urology
  • Oncology
  • Nephrology

Background:

  • Solid renal masses require accurate diagnosis and staging.
  • Renal cell carcinoma (RCC) management involves complex decisions.
  • Controversies exist in surgical and medical treatment approaches for RCC.

Purpose of the Study:

  • To review differential diagnoses for solid renal masses.
  • To discuss staging and controversial management of renal cell carcinoma (RCC).
  • To examine emerging surgical techniques and metastatic disease treatment.

Main Methods:

  • Literature review of differential diagnoses for solid renal masses.
  • Analysis of current staging systems for renal cell carcinoma.
  • Discussion of surgical management controversies (nephron-sparing surgery, lymphadenectomy, adrenalectomy).

Related Experiment Videos

  • Review of tumor thrombus management in vena cava.
  • Examination of metastatic RCC treatment (chemotherapy, immunotherapy).
  • Evaluation of laparoscopic nephrectomy's role.

    • Main Results:

    • Differential diagnoses for solid renal masses are presented.
    • Staging protocols for renal cell carcinoma are outlined.
    • Areas of management controversy, including surgical extent and indications, are discussed.
    • Treatment strategies for vena cava tumor thrombus are reviewed.
    • Current and emerging options for metastatic disease are analyzed.
    • The role of minimally invasive surgery, laparoscopic nephrectomy, is evaluated.

    Conclusions:

    • Accurate diagnosis and staging are crucial for solid renal masses.
    • Management of renal cell carcinoma involves addressing surgical controversies and metastatic potential.
    • Emerging techniques like laparoscopic nephrectomy are expanding treatment options.